385 related articles for article (PubMed ID: 21952072)
1. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P
Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072
[TBL] [Abstract][Full Text] [Related]
2. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
3. What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue.
Qureshi-Baig K; Ullmann P; Rodriguez F; Frasquilho S; Nazarov PV; Haan S; Letellier E
PLoS One; 2016; 11(1):e0146052. PubMed ID: 26745821
[TBL] [Abstract][Full Text] [Related]
4. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
5. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
Greber B; Lehrach H; Adjaye J
BMC Dev Biol; 2007 May; 7():46. PubMed ID: 17506876
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
8. Oct4 suppresses IR‑induced premature senescence in breast cancer cells through STAT3- and NF‑κB-mediated IL‑24 production.
Kim JY; Kim JC; Lee JY; Park MJ
Int J Oncol; 2018 Jul; 53(1):47-58. PubMed ID: 29749438
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
11. Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog.
Schreiber C; Kuch V; Umansky V; Sleeman JP
PLoS One; 2013; 8(2):e57465. PubMed ID: 23468991
[TBL] [Abstract][Full Text] [Related]
12. Breastmilk is a novel source of stem cells with multilineage differentiation potential.
Hassiotou F; Beltran A; Chetwynd E; Stuebe AM; Twigger AJ; Metzger P; Trengove N; Lai CT; Filgueira L; Blancafort P; Hartmann PE
Stem Cells; 2012 Oct; 30(10):2164-74. PubMed ID: 22865647
[TBL] [Abstract][Full Text] [Related]
13. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
du Puy L; Lopes SM; Haagsman HP; Roelen BA
Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
[TBL] [Abstract][Full Text] [Related]
14. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
[TBL] [Abstract][Full Text] [Related]
15. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
[TBL] [Abstract][Full Text] [Related]
16. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary Gland.
Hassiotou F; Hepworth AR; Beltran AS; Mathews MM; Stuebe AM; Hartmann PE; Filgueira L; Blancafort P
Front Oncol; 2013; 3():79. PubMed ID: 23596564
[TBL] [Abstract][Full Text] [Related]
18. Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data.
Sharov AA; Masui S; Sharova LV; Piao Y; Aiba K; Matoba R; Xin L; Niwa H; Ko MS
BMC Genomics; 2008 Jun; 9():269. PubMed ID: 18522731
[TBL] [Abstract][Full Text] [Related]
19. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
Nishi M; Sakai Y; Akutsu H; Nagashima Y; Quinn G; Masui S; Kimura H; Perrem K; Umezawa A; Yamamoto N; Lee SW; Ryo A
Oncogene; 2014 Jan; 33(5):643-52. PubMed ID: 23318426
[TBL] [Abstract][Full Text] [Related]
20. Effects of estrogen on the proportion of stem cells in the breast.
Simões BM; Piva M; Iriondo O; Comaills V; López-Ruiz JA; Zabalza I; Mieza JA; Acinas O; Vivanco MD
Breast Cancer Res Treat; 2011 Aug; 129(1):23-35. PubMed ID: 20859678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
